Hydrochlorothiazide: Is it a wise choice?

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 6, 2012, Pages 807-814

  DiNicolantonio, James J ^a  

^a Wegmans Pharmacy   (United States)

Author keywords

Chlorthalidone; Hydrochlorothiazide; Indapamide

Indexed keywords

AMILORIDE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; POTASSIUM SPARING DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG CHOICE; DRUG EFFICACY; DRUG NOMENCLATURE; DRUG POTENCY; DRUG SAFETY; HEART ARREST; HEART INFARCTION; HUMAN; HYPERTENSION; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PLEIOTROPY; PRACTICE GUIDELINE; PRESCRIPTION; RENAL PROTECTION; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; HYDROCHLOROTHIAZIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84858802627     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.670636     Document Type: Review

References (44)

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trail (ALLHAT). JAMA 2002;288:2981-97. Showed that chlorthalidone was non-inferior and superior to lisinopril and amlodipine for the primary and secondary outcomes, respectively
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64
3. Multiple Risk Factor Intervention Trail Research Group. Mortality after 10 1/2 years for hypertensive participants in the multiple risk factor intervention trail. Circulation 1990;82:1616-28. Showed worse effects on mortality, coronary artery disease, cardiovascular events and the reduction in left ventricular hypertrophy with HCTZ compared to chlorthalidone
4. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995;108:710-17
5. Beckett NS, Peters R, Fletcher AE, et al. for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98
6. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001;358:1033-41
7. Chobanian AV, Bakris GL, Black HR. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-71
8. Kurtz TW. Chlorthalidone: Don't call it "Thiazide-Like" anymore. Hypertension 2010;56:335-7
9. Leren P, Helgeland A. Oslo hypertension study. Drugs 1986;31:41-5. Showed that HCTZ significantly increases cardiovascular mortality compared to placebo despite a large reduction in blood pressure
10. Ernst ME, Lund BC. Renewed interest in chlorthalidone: Evidence from the veterans health administration. J Clin Hypertens 2010;12:927-34
11. Madkour H, Gadallah M, Riveline B, et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996;77:23B-5.B.
12. Carey PA, Sheridan DJ, de Cordoue A, et al. Effect of indapamide on left ventricular hypertrophy in hypertension: A meta-analysis. Am J Cardiol 1996;77:17B-9.B.
13. Ernst ME, Neaton JD, Grimm RH Jr, et al. for the Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension 2011;58:1001-7
14. Jamerson K, Devereux R, Bakris GL, et al. Efficacy and duration of benazepril plus amlodipine or hydrochlorthiazide on 24-h ambulatory systolic blood pressure control. Hypertension 2011;57:174-9
15. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-8
16. Meserli FH, Makani H, Benjo H, et al. Antihypertensive efficacy of HCTZ as evaluated by ABPM. A meta-analysis of randomized trials. J Am Coll Cardiol 2011;57:590-600. This meta-analysis showed the weak antihypertensive effects of HCT.Z.
17. Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001;37:1410-13
18. Witteman JC, Kannel WB, Wolf PA, et al. Aortic calcified plaques and cardiovascular disease (The Framingham Study). Am J Cardiol 1990;6:1060-4
19. Simon A, Gariepy J, Moyse D, et al. Differential effects of nifedipine and co-amilozide on the porgression of early carotid wall changes. Circulation 2001;103:2949-54
20. Fuchs FD. Diuretics: Still essential drugs for the management of hypertension. Expert Rev Cardiovasc Ther 2009;7:591-8
21. Bakris GL, Sarafidis PA, Weir MR, et al. for the ACCOMPLISH Trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of randomized controlled trial. Lancet 2010;375:1173-81. HCTZ was shown to be inferior to amlodipine for the primary endpoint despite similar blood pressure lowering
22. De Leeuw PW, Ruilope LM, Palmer CR, et al. Clinical significance of renal function in hypertensive patients at high risk: Results from the INSIGHT trial. Arch Intern Med 2004;164:2459-64
23. Voyaki SM, Staessen JA, Thijs L, et al. Follow-up renal function in treated and untreated older patients with isolated systolic hypertension. J Hypertens 2001;19:511-19
24. Madkour H, Gadallah M, Riveline B, et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996;77:23B-5.B.
25. Siscovick DS, Raughunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7
26. Wing LM, Ryan P, Beilin LJ, et al. Second Australian National Blood Pressure Study (ANBP2). Australian comparative outcome trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Expert Hypertens 1997;19:779-91
27. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability. Hypertension 2004;43:4-9
28. Multiple Risk Factor Intervention Trail Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trail. Circulation 1990;82:1616-28
29. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA 1990;263:1795-801
30. Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: A retrospective cohort analysis. Hypertension 2011;57:689-94
31. Ernst M, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-64
32. The Australian Therapeutic Trial in Mild Hypertension Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980;1:1261-7
33. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967;202:1028-34
34. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-52
35. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972;45:991-1004
36. Robinson D, Wellington K. Indapamide sustained release: A review of its use in the treatment of hypertension. Drugs 2006;66:257-71
37. Bataillard A, Schiavi P, Sassard J. Pharmacological properties of indapamide: Rationale for use in hypertension. Clin Pharmacokinet 1999;37:7-12
38. Ernst M, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-64
39. Kurtz WT. Chlorthalidone: Don't call it "Thiazide-Like" anymore. Hypertension 2010;56:335-7
40. Lottermoser K, Hertfelder HJ, Vetter H, et al. Fibrinolytic function in diuretic-induced volume depletion. Am J Hypertens 2000;13:359-63
41. Allen JH, McKenney JM, Stratton MA, et al. Antihypertensive effect of hydrochlorthiazide administered once or twice daily. Clin Pharm 1982;1:239-43
42. Jamerson K, Weber MA, Bakris GL, et al. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28
43. Fuchs FD. Diuretics: Still essential drugs for the management of hypertension. Expert Rev Cardiovasc Ther 2009;7:591-8
44. Barzilay JI, Davis BR, Cutler JA. Fasting glucose levels and incident diabetes mellitus in older non-diabetic adults randomized to receive 3 different classes of antihypertensive treatment: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006;166:2191-201